abstract |
A heteroarylcarboxamide of formula (I), wherein A, T, R 1 , R 2 and R 3 are as defined in the description and claims, and pharmaceutically acceptable salts thereof , Can be used in a method for the treatment of diseases that can be affected by the inhibition of plasma kallikrein. |